Great Point Partners LLC Protagonist Therapeutics, Inc Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$6.5 - $13.77 $6.21 Million - $13.2 Million
-955,618 Closed
0 $0
Q4 2018

Feb 15, 2019
SELL
$6.3 - $10.44 $169,035 - $280,115
-26,831 Reduced 2.73%
955,618 $6.43 Million
Q3 2018

Nov 14, 2018
SELL
$6.82 - $11.26 $3.35 Million - $5.53 Million
-491,160 Reduced 33.33%
982,449 $10.1 Million
Q2 2018

Aug 14, 2018
BUY
$5.99 - $9.1 $8.83 Million - $13.4 Million
1,473,609 New
1,473,609 $9.9 Million

Others Institutions Holding PTGX

# of Institutions
248
Shares Held
56.7M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.93B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email